Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Monash IVF Group Ltd ( (AU:MVF) ) has shared an announcement.
Monash IVF Group Limited has announced the appointment of Victoria Atkinson as a director of the company, effective 5 January 2026. According to the initial director’s interest notice lodged with the ASX, Atkinson currently holds no relevant interests in Monash IVF Group securities and has no disclosed interests in related contracts, indicating a starting position free of equity holdings as she joins the board.
The most recent analyst rating on (AU:MVF) stock is a Hold with a A$0.94 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Limited is an Australian healthcare company operating in the fertility services industry, specialising in assisted reproductive technologies and related medical services. The group focuses on providing in vitro fertilisation (IVF) and other fertility treatments to patients across its clinical network, positioning itself as a key player in the reproductive health and fertility market.
Average Trading Volume: 2,426,854
Technical Sentiment Signal: Sell
Current Market Cap: A$292.2M
Learn more about MVF stock on TipRanks’ Stock Analysis page.